You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 5, August 6, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Medical Practice
 •Medical Practice, Other
 •World Health
 •Public Health, Other
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Universal Access to HIV/AIDS Treatment

Promise and Problems

Harold W. Jaffe, MD, MA

JAMA. 2008;300(5):573-575.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The 21st century has witnessed unprecedented increases in funding for global health, driven mainly by efforts to address the HIV/AIDS epidemic. The US President's Emergency Plan for AIDS Relief (PEPFAR) is the largest single donor, having allocated approximately $13 billion for AIDS prevention, treatment, and care in developing countries and contributed $3 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria since the plan's inception in 2003.1 For the next 5 years, the president is seeking a $30 billion appropriation for PEPFAR while Congress is proposing to increase the appropriation to $50 billion and add funding for malaria and tuberculosis programs. In contrast, the World Health Organization (WHO) smallpox eradication program, conducted from 1967 through 1979, cost less than $2 billion (adjusted for inflation).2

Funding to provide antiretroviral treatment (ART) for HIV-infected individuals in developing countries is saving lives. The Joint United Nations . . . [Full Text of this Article]

Distortion of Local Priorities

Author Affiliations: Department of Public Health, University of Oxford, Oxford, United Kingdom.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

President's Emergency Plan for AIDS Relief: Health Development at the Crossroads
Gostin
JAMA 2008;300:2046-2048.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.